Beverly B. Green

Beverly B. Green

Auto-generated profile, based on publicly available information

Beverly B. Green

Kaiser Permanente Washington Health Research Institute, Seattle, Washington

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2015 in Journal of Medical Internet Research
Verified
Journal Article
Open access
SHSaee Hamine
Saee Hamine
EGEmily Gerth-Guyette
Emily Gerth-Guyette
DFDunia Faulx
Dunia Faulx
BGBeverly B Green
Beverly B Green
AGAmy Sarah Ginsburg
Amy Sarah Ginsburg
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

25 June 2008 in JAMA
Verified
Journal Article
Open access
PDF file
BGBeverly B. Green
Beverly B. Green
ACAndrea J. Cook
Andrea J. Cook
JRJames D. Ralston
James D. Ralston
PFPaul A. Fishman
Paul A. Fishman
SCSheryl L. Catz
Sheryl L. Catz
RTRobert S. Thompson
Robert S. Thompson
Hypertension is one of the leading causes of death worldwide.1 Almost 1 in 3 US adults has hypertension, defined as a sustained systolic and diastolic blood pressure (BP) of 140 and 90 mm Hg or higher, respectively.2,3 Lowering BP with antihypertensive medications decreases mortality and major disability from cardiovascular and renal disease. Hypertension, however, remains inadequately treated in the majority of affected individuals.4-6 In recent meta-analyses7,8 of quality-improvement strategies to lower BP, those targeting patients (education and self-monitoring) or adding a health care team member, such as a nurse or a pharmacist, to focus specifically on hypertension had the largest reductions in BP. Optimal methods for integrating these strategies into routine care were less certain.

5 March 2013 in Annals of Internal Medicine
Verified
Journal Article
Closed access
BGBeverly B. Green
Beverly B. Green
CWChing-Yun Wang
Ching-Yun Wang
MAMelissa L. Anderson
Melissa L. Anderson
JCJessica Chubak
Jessica Chubak
RMRichard T. Meenan
Richard T. Meenan
SFSharon Fuller
Sharon Fuller
Interventions to increase adherence to recommendations for colorectal cancer screening are needed. This randomized trial found that, compared with usual care, patients completed recommended screeni... Chinese translation Background: Screening decreases colorectal cancer (CRC) incidence and mortality, yet almost half of age-eligible patients are not screened at recommended intervals. Objective: T...

18 September 2017 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
KWKevin P. Weinfurt
Kevin P. Weinfurt
AHAdrian F. Hernandez
Adrian F. Hernandez
GCGloria Coronado
Gloria Coronado
LDLynn L. DeBar
Lynn L. DeBar
LDLaura M. Dember
Laura M. Dember
LCLesley H. Curtis
Lesley H. Curtis
The clinical research enterprise is not producing the evidence decision makers arguably need in a timely and cost effective manner; research currently involves the use of labor-intensive parallel systems that are separate from clinical care. The emergence of pragmatic clinical trials (PCTs) poses a possible solution: these large-scale trials are embedded within routine clinical care and often involve cluster randomization of hospitals, clinics, primary care providers, etc. Interventions can be implemented by health system personnel through usual communication channels and quality improvement infrastructure, and data collected as part of routine clinical care. However, experience with these trials is nascent and best practices regarding design operational, analytic, and reporting methodologies are undeveloped. To strengthen the national capacity to implement cost-effective, large-scale PCTs, the Common Fund of the National Institutes of Health created the Health Care Systems Research Collaboratory (Collaboratory) to support the design, execution, and dissemination of a series of demonstration projects using a pragmatic research design. In this article, we will describe the Collaboratory, highlight some of the challenges encountered and solutions developed thus far, and discuss remaining barriers and opportunities for large-scale evidence generation using PCTs. A planning phase is critical, and even with careful planning, new challenges arise during execution; comparisons between arms can be complicated by unanticipated changes. Early and ongoing engagement with both health care system leaders and front-line clinicians is critical for success. There is also marked uncertainty when applying existing ethical and regulatory frameworks to PCTS, and using existing electronic health records for data capture adds complexity.

19 June 2017 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
JCJennifer Coury
Jennifer Coury
JSJennifer L. Schneider
Jennifer L. Schneider
JRJennifer S. Rivelli
Jennifer S. Rivelli
APAmanda Petrik
Amanda Petrik
ESEvelyn Seibel
Evelyn Seibel
GCGloria Coronado
Gloria Coronado
The Plan-Do-Study-Act (PDSA) cycle is a commonly used improvement process in health care settings, although its documented use in pragmatic clinical research is rare. A recent pragmatic clinical research study, called the Strategies and Opportunities to STOP Colon Cancer in Priority Populations (STOP CRC), used this process to optimize the research implementation of an automated colon cancer screening outreach program in intervention clinics. We describe the process of using this PDSA approach, the selection of PDSA topics by clinic leaders, and project leaders’ reactions to using PDSA in pragmatic research. STOP CRC is a cluster-randomized pragmatic study that aims to test the effectiveness of a direct-mail fecal immunochemical testing (FIT) program involving eight Federally Qualified Health Centers in Oregon and California. We and a practice improvement specialist trained in the PDSA process delivered structured presentations to leaders of these centers; the presentations addressed how to apply the PDSA process to improve implementation of a mailed outreach program offering colorectal cancer screening through FIT tests. Center leaders submitted PDSA plans and delivered reports via webinar at quarterly meetings of the project’s advisory board. Project staff conducted one-on-one, 45-min interviews with project leads from each health center to assess the reaction to and value of the PDSA process in supporting the implementation of STOP CRC. Clinic-selected PDSA activities included refining the intervention staffing model, improving outreach materials, and changing workflow steps. Common benefits of using PDSA cycles in pragmatic research were that it provided a structure for staff to focus on improving the program and it allowed staff to test the change they wanted to see. A commonly reported challenge was measuring the success of the PDSA process with the available electronic medical record tools. Understanding how the PDSA process can be applied to pragmatic trials and the reaction of clinic staff to their use may help clinics integrate evidence-based interventions into their everyday care processes. Clinicaltrials.gov NCT01742065 . Registered October 31, 2013.

1 November 2014 in The Journal of the American Board of Family Medicine
Verified
Journal Article
Open access
PDF file
BGBeverly B. Green
Beverly B. Green
MAMelissa L. Anderson
Melissa L. Anderson
CWChing-Yun Wang
Ching-Yun Wang
SVSally W. Vernon
Sally W. Vernon
JCJessica Chubak
Jessica Chubak
SFSharon Fuller
Sharon Fuller
Background: Follow-up after a positive colorectal cancer screening test is necessary for screening to be effective. We hypothesized that nurse navigation would increase the completion of colonoscopy after a positive screening test. Methods: This study was conducted between 2008 and 2012 at 21 primary care medical centers in western Washington State. Participants in the Systems of Support to Increase Colorectal Cancer Screening study who had a positive fecal occult blood test (FOBT) or flexible sigmoidoscopy needing follow-up were randomized to usual care (UC) or a nurse navigator (navigation). UC included an electronic health record–based positive FOBT registry and physician reminder system. Navigation included UC plus care coordination and patient self-management support from a registered nurse who tracked and assisted patients until they completed or refused colonoscopy. The primary outcome was completion of colonoscopy within 6 months. After 6 months, both groups received navigation. Results: We randomized 147 participants with a positive FOBT or sigmoidoscopy. Completion of colonoscopy was higher in the intervention group at 6 months, but differences were not statistically significant (91.0% in navigation group vs 80.8% in UC group; adjusted difference, 10.1%; P = .10). Reasons for no or late colonoscopies included refusal, failure to schedule or missed appointments, concerns about risks or costs, and competing health concerns. Conclusions: Navigation did not lead to a statistically significant incremental benefit at 6 months. Impact: Follow-up rates after a positive colorectal cancer (CRC) screening test are high in a health care system where UC included a registry and physician reminders. Because of high follow-up rates in a health care system where UC included a registry and physician reminders, and small sample size, we cannot rule out incremental benefits of nurse navigation.